Vertex Pharmaceuticals Incorporated faces slowing Trikafta/Kaftrio sales and a stock-price divergence with peers. Click for ...

Artificial intelligence has entered a phase that feels both inevitable and strangely precarious. The hype is unmistakable. So is the sense that we are still early — too early — for the broader ...

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

XPO activity within the Russell 1000 highlights new annual trading highs, quarterly earnings performance, institutional ...

Snowflake performance within the NYSE Composite highlights quarterly earnings results, cloud data platform expansion, institutional activity, and competitive dynamics across enterprise analytics ...